Deep learning (DL) models that aid in predicting the risk of breast cancer are leading the way as artificial intelligence (AI) applications in radiology move from the theoretical to the practical. Constance Lehman, MD, PhD, professor of radiology at Harvard Medical School and director of breast imaging at Massachusetts General Hospital in Boston, discusses the potential for breast imagers to lead the way in AI cancer screening through their extensive experience with computer assisted diagnosis.

свернуть